Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:630543.
doi: 10.1155/2012/630543. Epub 2011 Jul 21.

Molecular pathogenesis of cholangiocarcinoma

Affiliations

Molecular pathogenesis of cholangiocarcinoma

G Fava et al. Int J Hepatol. 2012.

Abstract

Epidemiological data from the last years show an increasing trend of incidence and mortality of cholangiocarcinoma (CC) worldwide. Many pathophysiologic aspects of this neoplasia are still unknown and need to be fully discovered. However, several progresses were recently made in order to establish the molecular mechanisms involved in the transformation and growth of malignant cholangiocytes. The principal concept that at least seems to be established is that cholangiocarcinogenesis is a multistep cellular process evolving from a normal condition of the epithelial biliary cells through a chronic inflammation status ending with malignant transformation. The bad prognosis related to CC justifies why a better identification of the molecular mechanisms involved in the growth and progression of this cancer is required for the development of effective preventive measures and valid treatment regimens. This Paper describes the scientific progresses made in the last years in defining the molecular pathways implicated in the generation of this devastating disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Proposed mechanisms leading to transformation of normal biliary cells into malignant cholangiocytes. Cholangiocarcinoma cells express altered molecular mechanisms, which enhance cell proliferation, decrease apoptosis, and increase the capacity of tissue invasion, stromal proliferation, and angiogenesis.

References

    1. Lazaridis KN, Gores GJ. Cholangiocarcinoma. Gastroenterology. 2005;128(6):1655–1667. - PubMed
    1. Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer. 2002;2:p. 10. - PMC - PubMed
    1. Alvaro D, Crocetti E, Ferretti S, Bragazzi MC, Capocaccia R. Descriptive epidemiology of cholangiocarcinoma in Italy. Digestive and Liver Disease. 2010;42(7):490–495. - PubMed
    1. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. The Lancet. 2005;366(9493):1303–1314. - PubMed
    1. Fava G, Marzioni M, Benedetti A, et al. Molecular pathology of biliary tract cancers. Cancer Letters. 2007;250(2):155–167. - PubMed